Skip to Main Content

Skip Nav Destination

Article navigation

Research Watch| March 17 2023

Magrolimab plus Azacitidine Is Safe and Efficacious in High-Risk MDS

Author & Article Information

Online Issn: 2159-8290

Print Issn: 2159-8274

©2023 American Association for Cancer Research

2023

American Association for Cancer Research

Cancer Discov OF1.

https://doi.org/10.1158/2159-8290.CD-RW2023-040

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.